ofatumumab and radioimmunotherapy). Finally, hematopoietic stem cell transplantation (both autologous and allogeneic) remains a useful treatment strategy, although the optimal timing of such ...
225Ac-DOTA-YS5 radioimmunotherapy suppressed PSMA positive and deficient models, and FG-3246 is a novel antibody drug conjugate to CD46 in clinical trials (phase 1 with mCRPC with clinical activity).
Journal of Nuclear Medicine March 2025, jnumed.124.269067; DOI: https://doi.org/10.2967/jnumed.124.269067 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback